Management of occlusion and thrombosis associated with long-term indwelling central venous catheters

JL Baskin, CH Pui, U Reiss, JA Wilimas, ML Metzger… - The Lancet, 2009 - thelancet.com
Long-term central venous catheters (CVCs) are important instruments in the care of patients
with chronic illnesses, but catheter occlusions and catheter-related thromboses are common …

[HTML][HTML] Thrombolytic therapy for central venous catheter occlusion

JL Baskin, U Reiss, JA Wilimas, ML Metzger… - …, 2012 - ncbi.nlm.nih.gov
Thrombolytic therapy for central venous catheter occlusion - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Management of children with brain tumors in Paraguay

JL Baskin, E Lezcano, BS Kim, D Figueredo… - Neuro …, 2013 - academic.oup.com
Background Cure rates among children with brain tumors differ between low-income and
high-income countries. To evaluate causes of these differences, we analyzed aspects of care …

Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies

TE Warkentin, J Baskin-Miller… - … England Journal of …, 2023 - Mass Medical Soc
Thrombosis and Thrombocytopenia from Adenovirus Infection VITT is caused by antibodies
to PF4 that recognize the heparin-binding site. Thrombocytopenia and thrombosis …

Effectiveness of clinical decision support based intervention in the improvement of care for adult sickle cell disease patients in primary care

…, RJ Tanner, MM Hulihan, J Baskin… - The Journal of the …, 2018 - Am Board Family Med
Introduction: Although most patients with rare diseases like sickle cell disease (SCD) are
treated in the primary care setting, primary care physicians may find it challenging to keep …

Managing the cerebrovascular complications of sickle cell disease: current perspectives

J Light, M Boucher, J Baskin-Miller… - Journal of Blood …, 2023 - Taylor & Francis
The importance of protecting brain function for people with sickle cell disease (SCD) cannot
be overstated. SCD is associated with multiple cerebrovascular complications that threaten …

Treatment of alpha(0)-thalassemia (--SEA/--SEA) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?

RH Chmait, JL Baskin, S Carson, LM Randolph… - …, 2015 - Taylor & Francis
Objective and importance Homozygous Southeast Asian alpha-thalassemia mutation (--
SEA /-- SEA ) results in deletion of all alpha-globin genes (alpha(0)-thalassemia). Since all …

[HTML][HTML] Challenges in the management of the transgender patient with sickle cell disease

…, R Naik, CM Takemoto, J Baskin… - American journal of …, 2018 - ncbi.nlm.nih.gov
Patients with sickle cell disease (SCD) who identify as transgender pose a management
challenge. Standard care for transgender patients is cross-sex hormone therapy (CSHT), but …

How do I reduce variation in red blood cell transfusion practices in a large integrated health care system?

…, S Weiss, YA Park, R Lu, J Baskin‐Miller… - …, 2023 - Wiley Online Library
Background Reducing variation in transfusion practices can prevent unwarranted transfusions,
an outcome that improves quality of care and patient safety, while lowering costs and …

Utilization, trust and satisfaction with health care in adult sickle cell disease patients

J Baskin, A Nord, K Russell, P Shah… - Authorea …, 2020 - advance.sagepub.com
Introduction: Transition from pediatric to adult care for emerging adults with sickle cell disease
(SCD) has been challenging due to limited availability of experienced adult providers and …